The consortium led by Sonichem has secured funding from Innovate UK’s 'Resource efficiency for materials and manufacturing' programme. The funding will help the project to accelerate the development of the proprietary Sonichem ultrasound technology and the production of renewable, cost-effective alternatives to petrochemicals.
Expected to begin operations this year, the wastewater treatment plant is almost 100 % automated and will handle variable bio-treater wastewater. The plant will make use of Ecolab's ultrafiltration and reverse osmosis membrane system.
A consortium of 15 companies including Neste have successfully concluded a joint ‘E-Fuel research project’ in which high temperature electrolysis (SOEC), carbon capture, and hydrocarbon synthesis technologies were demonstrated and production of synthetic e-fuels was also accelerated.
How long does it take for something groundbreaking to become business-as-usual? At what point do those nice-to-haves become the norm? How exactly does it happen? And, perhaps most importantly of all, how do you keep progressing after what was once exceptional becomes the default? The promise of a ‘sustainable future’ creates many questions – questions that can only be answered with collaboration.
Eastman has plans to develop its second molecular recycling project in the U.S.A. The Longview site in Texas has been selected by the company for developing the project.
Topsoe has received a massive funding of 94 million euros from EU’s Innovation Fund for developing a solid oxide electrolyzer cells factory in Denmark. The factory is expected to manufacture advanced, energy efficient solid oxide electrolyzer cells which are used in the production of green hydrogen.
Dow and Procter & Gamble have plans to develop a new recycling technology which mainly focuses on the conversion of hard-to-recycle plastic packaging into recycled polyethylene with near-virgin quality and a low greenhouse gas emissions footprint.
The new unit is expected to increase the company’s production capacity by 20 % as compared to the current capacity of 200 million packages per year. The site will also enable the production of one billion additional penicillin tablets and a doubling of the quantity of powder oral suspensions which are mainly used in pediatric medicines.
On December 21, 2023, BASF, Letter One and Harbour Energy reached an agreement on the future of Dea Wintershall's exploration and production business. The business, excluding Russia-related activities, is to be transferred to Harbour Energy.